Equity Analysis

Quarterly Results

    Concord Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543960
    INE338H01029
    152.0404927
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    CONCORDBIO
    64.66
    21253.3
    EPS(TTM)
    Face Value()
    Div & Yield %:
    31.42
    1
    0.43
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales310.18215.80318.97
Other Operating Income0.000.000.00
Other Income 10.0310.3110.81
Total Income320.21226.11329.78
Total Expenditure 173.50134.52184.68
PBIDT146.7091.59145.10
Interest 0.100.240.46
PBDT146.6191.35144.64
Depreciation13.3113.1813.72
Tax34.0619.3929.98
Fringe Benefit Tax0.000.000.00
Deferred Tax0.530.533.73
Reported Profit After Tax98.7058.2497.21
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item98.7058.2497.21
EPS (Unit Curr.)9.435.579.29
EPS (Adj) (Unit Curr.)9.435.579.29
Calculated EPS (Unit Curr.)9.435.579.29
Calculated EPS (Adj) (Unit Curr.)9.435.579.29
Calculated EPS (Ann.) (Unit Curr.)37.7422.2737.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)37.7422.2737.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4610.4610.46
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)47.3042.4445.49
PBDTM(%)47.2742.3345.35
PATM(%)31.8226.9930.48
Dividend Per Share(Rs)0.000.000.00
Diluted EPS9.435.579.29